Latest Heparin Stories
- Phase I study results presented at American Society of Hematology Annual Meeting RIDGEFIELD, Conn., Dec. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
TAINAN, Nov. 10, 2014 /PRNewswire/ -- ScinoPharm Taiwan, Ltd (TWSE: 1789) and Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Patented formulation of alkalized lidocaine and heparin has been prescribed as a compounded drug for individual patients in different dosages in thousands of insurance reimbursed bladder instillation
New insight has been gained into treating an inherited disorder that creates serious neurological and behavioral disabilities in children and usually leads to death in the teen years.
In a scientific first, Harvard Stem Cell Institute scientists have successfully grown the cells that line the blood vessels—called vascular endothelial cells—from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.
Controlled by an infrared laser, gold nanoparticles can now be used to turn blood clotting on and off - a useful tool for doctors who are trying to control clotting during surgery.
Researchers have designed tiny, light-controlled gold particles that can release DNA controls to switch blood clotting off and on.
- Growing in low tufty patches.